In the BioHarmony Drug Report Database

"Preview" Icon

Tipranavir

Aptivus (tipranavir) is a small molecule pharmaceutical. Tipranavir was first approved as Aptivus on 2005-06-22. It is used to treat acquired immunodeficiency syndrome in the USA. It has been approved in Europe to treat HIV infections.

 

Trade Name

 

Aptivus
 

Common Name

 

tipranavir
 

ChEMBL ID

 

CHEMBL222559
 

Indication

 

acquired immunodeficiency syndrome, hiv infections
 

Drug Class

 

Antivirals: HIV protease inhibitors (saquinavir type)

Image (chem structure or protein)

Tipranavir structure rendering